Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 08-Mar-13 1:39 PM View:  | Mast Erle T Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 06-Mar-13 | Disposition | 39,162 | -- | -- | (100%) 39.16K to 0 | |
| 08-Mar-13 1:32 PM View: | Emster Kurt von Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 06-Mar-13 | Disposition | 3,214 | -- | -- | (100%) 3.21K to 0 | |
| 08-Mar-13 1:36 PM View: | Dorsey Brian SVP, Technical Operations | Somaxon Pharmaceuticals, Inc. (SOMX) | 06-Mar-13 | Disposition | 28,340 | -- | -- | (100%) 28.34K to 0 | |
| 08-Mar-13 1:41 PM View: | Eagle Michael L Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 06-Mar-13 | Disposition | 38,671 | -- | -- | (100%) 38.67K to 0 | |
| 08-Mar-13 1:23 PM View: | Hale David F Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 06-Mar-13 | Disposition | 70,388 | -- | -- | (64%) 110.49K to 40.1K | |
| 08-Mar-13 1:33 PM View: | Onaitis Matthew SVP, General Counsel | Somaxon Pharmaceuticals, Inc. (SOMX) | 06-Mar-13 | Disposition | 47,098 | -- | -- | (100%) 47.1K to 0 | |
| 08-Mar-13 1:40 PM View: | Cobb Terrell Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 06-Mar-13 | Disposition | 33,044 | -- | -- | (100%) 33.04K to 0 | |
| 08-Mar-13 1:38 PM View: | Hasnain Faheem Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 06-Mar-13 | Disposition | 27,974 | -- | -- | (100%) 27.97K to 0 | |
| 08-Mar-13 1:32 PM View: | Emster Kurt von Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 06-Mar-13 | Disposition | 31,800 | -- | -- | (91%) 35.01K to 3.21K | |
| 08-Mar-13 1:23 PM View: | Hale David F Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 06-Mar-13 | Disposition | 40,098 | -- | -- | (100%) 40.1K to 0 | |
| 08-Mar-13 1:29 PM View: | Nguyen Tran SVP and CFO | Somaxon Pharmaceuticals, Inc. (SOMX) | 06-Mar-13 | Disposition | 42,419 | -- | -- | (100%) 42.42K to 0 | |
| 08-Mar-13 1:25 PM View: | Pascoe Richard W President and CEO Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 06-Mar-13 | Disposition | 98,294 | -- | -- | (100%) 98.29K to 0 | |
| 03-Jan-13 6:54 PM View: | Nguyen Tran SVP and CFO | Somaxon Pharmaceuticals, Inc. (SOMX) | 02-Jan-13 | Market Sale (Planned) | 412 | $3.08 | $1,268.96 | (< 1%) 50.36K to 49.95K | 1% |
| 03-Jan-13 6:51 PM View: | Emster Kurt von Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 31-Dec-12 | Grant | 6,541 | -- | -- | 27% 24.35K to 30.89K | |
| 03-Jan-13 6:45 PM View: | Hale David F Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 31-Dec-12 | Grant | 16,033 | -- | -- | 17% 94.45K to 110.49K | |
| 03-Jan-13 7:01 PM View: | Onaitis Matthew SVP, General Counsel | Somaxon Pharmaceuticals, Inc. (SOMX) | 31-Dec-12 | Grant | 1,494 | -- | -- | 3% 53.34K to 54.84K | |
| 03-Jan-13 6:45 PM View: | Cobb Terrell Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 31-Dec-12 | Grant | 6,787 | -- | -- | 31% 22.24K to 29.03K | |
| 03-Jan-13 6:47 PM View: | Hasnain Faheem Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 31-Dec-12 | Grant | 7,230 | -- | -- | 42% 17.29K to 24.52K | |
| 03-Jan-13 6:54 PM View: | Nguyen Tran SVP and CFO | Somaxon Pharmaceuticals, Inc. (SOMX) | 31-Dec-12 | Grant | 1,494 | -- | -- | 3% 48.87K to 50.36K | |
| 03-Jan-13 6:53 PM View: | Pascoe Richard W President and CEO Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 31-Dec-12 | Grant | 7,142 | -- | -- | 7% 97.78K to 104.93K | |
| 03-Jan-13 6:50 PM View: | Mast Erle T Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 31-Dec-12 | Grant | 7,820 | -- | -- | 29% 26.96K to 34.78K | |
| 03-Jan-13 7:00 PM View: | Dorsey Brian SVP, Technical Operations | Somaxon Pharmaceuticals, Inc. (SOMX) | 31-Dec-12 | Grant | 1,494 | -- | -- | 3% 50.77K to 52.26K | |
| 03-Jan-13 6:46 PM View: | Eagle Michael L Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 31-Dec-12 | Grant | 7,918 | -- | -- | 30% 26.8K to 34.72K | |
| 20-Nov-12 1:59 PM View: | Onaitis Matthew SVP, General Counsel | Somaxon Pharmaceuticals, Inc. (SOMX) | 16-Nov-12 | Grant | 30,000 | -- | -- | 111% 27.09K to 57.09K | |
| 20-Nov-12 2:02 PM View: | Nguyen Tran SVP and CFO | Somaxon Pharmaceuticals, Inc. (SOMX) | 16-Nov-12 | Grant | 30,000 | -- | -- | 133% 22.62K to 52.62K | |
| 20-Nov-12 1:58 PM View: | Pascoe Richard W President and CEO Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 16-Nov-12 | Grant | 50,000 | -- | -- | 93% 54.03K to 104.03K | |
| 20-Nov-12 2:01 PM View: | Dorsey Brian SVP, Technical Operations | Somaxon Pharmaceuticals, Inc. (SOMX) | 16-Nov-12 | Grant | 30,000 | -- | -- | 144% 20.77K to 50.77K | |
| 02-Oct-12 9:09 PM View: | Cobb Terrell Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 30-Sep-12 | Grant | 42,414 | -- | -- | 31% 135.52K to 177.94K | |
| 02-Oct-12 9:14 PM View: | Hasnain Faheem Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 30-Sep-12 | Grant | 32,586 | -- | -- | 31% 105.73K to 138.32K | |
| 02-Oct-12 9:10 PM View: | Dorsey Brian SVP, Technical Operations | Somaxon Pharmaceuticals, Inc. (SOMX) | 30-Sep-12 | Grant | 15,716 | -- | -- | 10% 150.44K to 166.16K | |
| 02-Oct-12 9:16 PM View: | Mast Erle T Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 30-Sep-12 | Grant | 57,414 | -- | -- | 36% 158.28K to 215.69K | |
| 02-Oct-12 9:11 PM View: | Eagle Michael L Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 30-Sep-12 | Grant | 52,241 | -- | -- | 32% 162.18K to 214.42K | |
| 02-Oct-12 9:18 PM View: | Onaitis Matthew SVP, General Counsel | Somaxon Pharmaceuticals, Inc. (SOMX) | 30-Sep-12 | Grant | 15,716 | -- | -- | 9% 171.03K to 186.75K | |
| 02-Oct-12 9:12 PM View: | Emster Kurt von Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 30-Sep-12 | Grant | 48,103 | -- | -- | 33% 146.71K to 194.82K | |
| 02-Oct-12 9:13 PM View: | Hale David F Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 30-Sep-12 | Grant | 137,586 | -- | -- | 22% 618.05K to 755.63K | |
| 02-Oct-12 9:16 PM View: | Nguyen Tran SVP and CFO | Somaxon Pharmaceuticals, Inc. (SOMX) | 30-Sep-12 | Grant | 15,716 | -- | -- | 12% 135.22K to 150.94K | |
| 02-Oct-12 9:18 PM View: | Pascoe Richard W President and CEO Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 30-Sep-12 | Grant | 75,119 | -- | -- | 24% 307.16K to 382.28K | |
| 06-Sep-12 5:45 PM View: | Emster Kurt von Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 05-Sep-12 | Market Sale | 1,367 | $0.29 | $396.43 | (5%) 27.08K to 25.71K | 35% |
| 10-Jul-12 2:11 PM View: | Mpm Bioventures III Qp Lp 10% Owner | Somaxon Pharmaceuticals, Inc. (SOMX) | 09-Jul-12 | Market Sale Duplicate | 1,624,570 | $0.31 | $498,744.00 | (28%) 5.8M to 4.18M | (30%) |
| 10-Jul-12 2:10 PM View: | Evnin Luke 10% Owner | Somaxon Pharmaceuticals, Inc. (SOMX) | 09-Jul-12 | Market Sale | 1,624,570 | $0.31 | $498,744.00 | (28%) 5.8M to 4.18M | (30%) |
| 10-Jul-12 2:10 PM View: | Evnin Luke 10% Owner | Somaxon Pharmaceuticals, Inc. (SOMX) | 06-Jul-12 | Market Sale | 671,217 | $0.29 | $195,324.00 | (10%) 6.47M to 5.8M | 33% |
| 10-Jul-12 2:11 PM View: | Mpm Bioventures III Qp Lp 10% Owner | Somaxon Pharmaceuticals, Inc. (SOMX) | 06-Jul-12 | Market Sale Duplicate | 671,217 | $0.29 | $195,324.00 | (10%) 6.47M to 5.8M | 33% |
| 05-Jul-12 11:59 AM View: | Evnin Luke 10% Owner | Somaxon Pharmaceuticals, Inc. (SOMX) | 03-Jul-12 | Market Sale | 98,210 | $0.29 | $28,480.90 | (1%) 7.34M to 7.24M | 33% |
| 03-Jul-12 3:36 PM View: | Eagle Michael L Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 02-Jul-12 | Grant | 57,368 | -- | -- | 55% 104.81K to 162.18K | |
| 03-Jul-12 4:56 PM View: | Onaitis Matthew SVP, General Counsel | Somaxon Pharmaceuticals, Inc. (SOMX) | 02-Jul-12 | Grant | 15,992 | -- | -- | 10% 155.04K to 171.03K | |
| 03-Jul-12 3:43 PM View: | Emster Kurt von Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 02-Jul-12 | Grant | 61,579 | -- | -- | 71% 86.5K to 148.08K | |
| 03-Jul-12 3:32 PM View: | Hale David F Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 02-Jul-12 | Grant | 144,951 | -- | -- | 31% 473.1K to 618.05K | |
| 03-Jul-12 4:57 PM View: | Nguyen Tran SVP and CFO | Somaxon Pharmaceuticals, Inc. (SOMX) | 02-Jul-12 | Grant | 15,992 | -- | -- | 13% 119.23K to 135.22K | |
| 05-Jul-12 12:01 PM View: | Mpm Bioventures III Qp Lp 10% Owner | Somaxon Pharmaceuticals, Inc. (SOMX) | 02-Jul-12 | Market Sale | 178,558 | $0.29 | $51,781.80 | (2%) 7.42M to 7.24M | 32% |
| 03-Jul-12 4:52 PM View: | Pascoe Richard W President and CEO Director | Somaxon Pharmaceuticals, Inc. (SOMX) | 02-Jul-12 | Grant | 76,437 | -- | -- | 33% 230.73K to 307.16K |
